PubMed · 2021

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.. N Engl J Med.

N Engl J Med

View original source
XRedditFacebook

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.